GABA supplements have not been studied in pregnant women, and the United States Pharmacopeia advises caution for pregnant and lactating women due to the complete absence of safety data. No human clinical trials, case reports, or even spontaneous adverse event reports exist for GABA supplement use during pregnancy. That alone is reason enough to avoid it, but the limited research that does exist raises several specific concerns.
Why the Lack of Data Matters
GABA is a neurotransmitter your body produces naturally, and it plays a calming role in the nervous system. Supplemental GABA is sold over the counter for sleep and anxiety, which makes it feel low-risk. But “natural” and “available without a prescription” don’t mean safe in pregnancy. The USP safety review found zero studies on GABA’s effects during pregnancy or breastfeeding. When a substance has no pregnancy safety profile at all, the default recommendation is to avoid it.
GABA supplements also affect the endocrine system, increasing levels of growth hormone and prolactin. Both of these hormones are already shifting dramatically during pregnancy, and introducing an outside influence on that balance without any data to guide dosing or timing is a gamble with no known payoff.
What Animal and Lab Research Shows
The research that does exist comes from animal studies and lab experiments on cells, and the findings are not reassuring. A study on mouse embryos found that exposing preimplantation embryos (the very earliest stage of development) to GABA significantly increased cell death. Both types of GABA receptors are present in early embryos, and activating them negatively affected embryo viability. When researchers blocked those receptors, the harmful effects stopped, confirming that the damage was directly tied to GABA signaling.
Separately, research on human placental cells found that activating a specific GABA receptor increased cell death in first-trimester placental tissue. The placenta is the lifeline between you and the fetus, so anything that compromises its cells early in pregnancy is concerning.
Risks to Fetal Brain Development
GABA plays a complex and tightly regulated role in fetal brain development, and artificially boosting it can disrupt that process. Animal studies on drugs that increase GABA levels in the brain have shown real consequences. Mice exposed to elevated GABA during early development showed delayed motor and sensory reflexes, reduced mobility, impaired object recognition, and problems with spatial learning and memory. These effects persisted into adulthood.
The brain changes behind those behavioral problems were measurable. Researchers found altered cell density in the hippocampus (a brain region critical for learning and memory) shortly after birth, and lower cell density in the motor cortex of adult mice that had been exposed during development. In newborn rats, activating GABA receptors caused significant cell death in the hippocampus within a week of treatment. The developing brain appears especially vulnerable to excess GABA stimulation in the period around birth.
GABA Analogs and Pregnancy Outcomes
GABA analogs are prescription medications designed to mimic or enhance GABA’s effects, and they offer the closest window into what boosting GABA signaling might do during pregnancy. A meta-analysis of eight studies found that exposure to GABA analogs during pregnancy was associated with a 56% higher risk of preterm birth and a 64% higher risk of spontaneous miscarriage compared to no exposure. The risk of pregnancy termination was three times higher in the exposed group.
These drugs did not appear to increase the risk of birth defects or growth restriction. But preterm birth and miscarriage are serious outcomes on their own. It’s worth noting that the women in these studies were taking prescription medications for conditions like epilepsy or chronic pain, so the doses were likely higher and more consistent than a typical supplement. Still, the pattern of harm from enhanced GABA signaling during pregnancy is consistent across multiple lines of evidence.
Safer Ways to Manage Sleep and Anxiety
If you’re reaching for GABA because you can’t sleep or you’re struggling with anxiety, you’re not alone. Insomnia is extremely common in pregnancy. Fortunately, several approaches have evidence behind them and a better safety profile.
Cognitive behavioral therapy (CBT) is considered the gold standard for insomnia in the general population, and it’s safe during pregnancy. It involves structured techniques like going to bed only when you’re sleepy, getting out of bed during long awakenings, and establishing regular sleep and wake times. Other non-drug approaches that may help include prenatal yoga, meditation, massage, exercise, and acupuncture. Practical adjustments matter too: minimizing fluids before bed to reduce nighttime bathroom trips, using pillows for physical support, and applying local heat to sore areas.
For more severe insomnia, antihistamines like diphenhydramine are widely used in pregnancy for nausea and allergy symptoms and have been studied for sleep. Data from the National Birth Defects Prevention Study found no increased risk of birth defects or heart problems from antihistamine use in early pregnancy. In one trial of pregnant women at 26 to 30 weeks, diphenhydramine improved sleep quality as effectively as a prescription antidepressant.
Breastfeeding Carries the Same Unknowns
The safety picture doesn’t improve after delivery. No studies have examined whether supplemental GABA passes into breast milk or how it might affect a nursing infant. The same USP review that flagged concerns for pregnancy also advises caution during lactation, again because of GABA’s effects on neurotransmitters and hormones like growth hormone and prolactin. Until research fills this gap, the same caution applies while breastfeeding.